VR Adviser’s ADARx Pharmaceuticals ADRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$32.4M Buy
+1,625,793
New +$32.5M 1.58% 18

Other funds holding ADRX

VR Adviser's ADRX Position: Q3 2026 in Review

VR Adviser opened a new position in ADARx Pharmaceuticals (ADRX) in Q3 2026: 1,625,793 shares worth $32.4M. The stake represents 1.58% of the portfolio and ranks #18 among its holdings.

62 funds tracked by Wall St. Rank hold ADRX as of Q3 2026.

  • VR Adviser held 1,625,793 shares of ADARx Pharmaceuticals worth $32.4M as of Q3 2026.
  • ADARx Pharmaceuticals was a new VR Adviser position in Q3 2026.
  • ADARx Pharmaceuticals made up 1.58% of VR Adviser's portfolio in Q3 2026, its #18 holding.
  • 62 funds tracked by Wall St. Rank held ADARx Pharmaceuticals as of Q3 2026.

Based on VR Adviser's 13F filing for Q3 2026, filed 16 Nov 2026.